Following from an inspection in late January, the French National Agency for Medicines and Health Products Safety found Huzhou Sunflower Pharmaceutical to be non-compliant with GMPs. Twenty-seven deficiencies were observed, with those defined as critical or major being: ● particle contamination ● disposal of quality documents ● deficient water system ● multiple Certificates of Analysis for the same batch, and ● deficient equipment management.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
